Wells Fargo Maintains Overweight on Oscar Health, Raises Price Target to $24
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Stephen Baxter has maintained an Overweight rating on Oscar Health (OSCR) and increased the price target from $20 to $24.

May 09, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo analyst Stephen Baxter reaffirmed an Overweight rating on Oscar Health and raised the price target to $24 from $20.
The increase in price target by a reputable analyst like Stephen Baxter suggests a positive outlook on Oscar Health's stock, likely due to strong company fundamentals or market position. This endorsement can lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100